Novatek International is pleased to announce that UK-based pharmaceutical company Amdipharm Mercury Company Limited (AMCo) has chosen Nova-Stability from the Nova-LIMS Product Suite for automating and managing their stability process at their Mumbai facility in India. Nova-Stability’s powerful functionality is backed by hundreds of user requirements incorporating the in-depth knowledge of numerous experts in the best quality practices driving higher adoption and greater operational efficiency to our clients. Novatek International is pleased to welcome AMCo to our family of many other Nova-Stability clientele such as Quanterix, Hospira, Inc., Merck & Co., Inc., Pfizer, Sanofi-Aventis, Paxvax, Novartis, Medline, Ranbaxy, Biovest International, Inc., Jubilant HollisterStier, Amoun Pharmaceuticals, Virbac USA, and Bayer. Our services from delivery to maintenance, are second to none and our implementation and validation timelines easily beat the industry expectations every time! We invite you to evaluate our applications for yourself and find out why Novatek’s Suite of Quality Management software has become the industry standard. Come see us at the 1st PDA Europe Annual Meeting this June 28-29, 2016 in Berlin, Germany to learn more about Nova-Stability and our entire Suite of Nova-LIMS.
About Amdipharm Mercury Company Limited (AMCo):
AMCo is a rapidly growing international pharmaceutical company, committed to bringing its portfolio of niche medicines to patients in more than 100 countries. AMCo is the result of the merger in 2013 of Amdipharm and the Mercury Pharma Group.
